Min Ni

12.1k total citations · 2 hit papers
97 papers, 5.5k citations indexed

About

Min Ni is a scholar working on Molecular Biology, Cell Biology and Cancer Research. According to data from OpenAlex, Min Ni has authored 97 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Molecular Biology, 14 papers in Cell Biology and 14 papers in Cancer Research. Recurrent topics in Min Ni's work include Endoplasmic Reticulum Stress and Disease (11 papers), Metabolism and Genetic Disorders (11 papers) and Mitochondrial Function and Pathology (9 papers). Min Ni is often cited by papers focused on Endoplasmic Reticulum Stress and Disease (11 papers), Metabolism and Genetic Disorders (11 papers) and Mitochondrial Function and Pathology (9 papers). Min Ni collaborates with scholars based in China, United States and Canada. Min Ni's co-authors include Amy S. Lee, Yi Zhang, Jian Xu, Myles Brown, X. Shirley Liu, David R. Hinton, E. Barrón, Jiaxi Li, Fu‐Ming Shen and Shannon T. Bailey and has published in prestigious journals such as Science, Cell and Journal of Biological Chemistry.

In The Last Decade

Min Ni

89 papers receiving 5.5k citations

Hit Papers

ER chaperones in mammalian development and human diseases 2007 2026 2013 2019 2007 2011 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Min Ni China 31 3.2k 1.7k 1.1k 627 613 97 5.5k
Éva Szegezdi Ireland 31 3.1k 1.0× 2.0k 1.1× 1.4k 1.2× 440 0.7× 600 1.0× 80 5.7k
Thomas G. Gillette United States 39 3.3k 1.1× 821 0.5× 1.1k 1.0× 409 0.7× 545 0.9× 67 5.6k
Yu Jiang United States 45 3.6k 1.1× 1.0k 0.6× 702 0.6× 686 1.1× 593 1.0× 119 5.1k
Sanjeev Gupta Ireland 29 2.7k 0.9× 1.8k 1.0× 1.2k 1.1× 382 0.6× 307 0.5× 62 4.5k
Navid Sadri United States 17 2.2k 0.7× 1.6k 0.9× 745 0.7× 539 0.9× 292 0.5× 43 3.8k
Hideki Nishitoh Japan 37 5.3k 1.7× 2.1k 1.2× 1.2k 1.1× 767 1.2× 531 0.9× 64 8.2k
Marco Corazzari Italy 35 2.7k 0.9× 1.4k 0.8× 2.7k 2.5× 589 0.9× 609 1.0× 87 5.6k
Hai‐Xin Yuan China 22 2.8k 0.9× 2.0k 1.1× 1.8k 1.7× 626 1.0× 384 0.6× 45 5.0k
Clark Distelhorst United States 43 3.8k 1.2× 1.1k 0.6× 835 0.8× 469 0.7× 547 0.9× 82 5.3k
Uwe Knippschild Germany 40 3.5k 1.1× 657 0.4× 975 0.9× 714 1.1× 1.5k 2.4× 134 6.0k

Countries citing papers authored by Min Ni

Since Specialization
Citations

This map shows the geographic impact of Min Ni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min Ni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min Ni more than expected).

Fields of papers citing papers by Min Ni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Min Ni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min Ni. The network helps show where Min Ni may publish in the future.

Co-authorship network of co-authors of Min Ni

This figure shows the co-authorship network connecting the top 25 collaborators of Min Ni. A scholar is included among the top collaborators of Min Ni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Min Ni. Min Ni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hua, Shao‐Ying, Xinyi Chen, Min Ni, et al.. (2025). ZeXieYin formula alleviates atherosclerosis by regulating SBAs levels through the FXR/FGF15 pathway and restoring intestinal barrier integrity. Chinese Medicine. 20(1). 68–68. 1 indexed citations
2.
Fukuda, Yu, John P. Lynch, Abhijat Sheth, et al.. (2025). Somatic mtDNA mutation burden shapes metabolic plasticity in leukemogenesis. Science Advances. 11(1). eads8489–eads8489.
4.
Ni, Min, et al.. (2025). Adipose-androgen crosstalk in polycystic ovary syndrome: mechanisms and therapeutic implications. Frontiers in Endocrinology. 16. 1731179–1731179.
5.
Li, Hongxia, Chenxi Xia, Shu-Chi Huang, et al.. (2024). A deep neural network potential model for theoretically predicting thermal transport, mechanical properties of multi-layered graphitic carbon nitride with molecular dynamics. International Communications in Heat and Mass Transfer. 160. 108354–108354. 4 indexed citations
6.
Tian, Cheng, Wentao Yang, Xiaoli Liu, et al.. (2024). HKDC1 promotes liver cancer stemness under hypoxia through stabilizing β-catenin. Hepatology. 81(6). 1685–1699. 8 indexed citations
7.
Gao, Qi, Dan Bi, Bingbing Li, et al.. (2024). The Association Between Branched-Chain Amino Acid Concentrations and the Risk of Autism Spectrum Disorder in Preschool-Aged Children. Molecular Neurobiology. 61(8). 6031–6044. 4 indexed citations
8.
Pachnis, Panayotis, et al.. (2023). Partial N‐acetyl glutamate synthase deficiency presenting as postpartum hyperammonemia: Diagnosis and subsequent pregnancy management. JIMD Reports. 64(6). 403–409. 2 indexed citations
9.
Harris, Robert C., Panayotis Pachnis, Hongli Chen, et al.. (2023). Novel pathogenicUQCRC2variants in a female with normal neurodevelopment. Molecular Case Studies. 9(4). a006295–a006295. 2 indexed citations
10.
Gu, Zhimin, Gen Zhang, Richard Wynn, et al.. (2022). Metabolon formation regulates branched-chain amino acid oxidation and homeostasis. Nature Metabolism. 4(12). 1775–1791. 22 indexed citations
11.
Ni, Min, Liang Zhao, Wenjing Zhang, et al.. (2021). Pharmacokinetics of colistin in cerebrospinal fluid after intraventricular administration alone in intracranial infections. International Journal of Antimicrobial Agents. 57(3). 106281–106281. 10 indexed citations
12.
Li, Kailong, Yuannyu Zhang, Xin Liu, et al.. (2020). Noncoding Variants Connect Enhancer Dysregulation with Nuclear Receptor Signaling in Hematopoietic Malignancies. Cancer Discovery. 10(5). 724–745. 30 indexed citations
13.
Ni, Min, Yi Zhao, Wenjing Zhang, et al.. (2020). microRNA‐802 accelerates hepatocellular carcinoma growth by targeting RUNX3. Journal of Cellular Physiology. 235(10). 7128–7135. 16 indexed citations
14.
Ni, Min, et al.. (2020). Autologous adipose-derived stem cells for the treatment of Crohn’s fistula-in-ano: an open-label, controlled trial. Stem Cell Research & Therapy. 11(1). 124–124. 47 indexed citations
15.
Sun, Sijia, Wenxiang Cao, Min Ni, et al.. (2020). Excessive ROS production and enhanced autophagy contribute to myocardial injury induced by branched-chain amino acids: Roles for the AMPK-ULK1 signaling pathway and α7nAChR. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1867(1). 165980–165980. 46 indexed citations
17.
Li, Dongjie, Hui Fu, Ting Zhao, Min Ni, & Fu‐Ming Shen. (2016). Exercise-stimulated FGF23 promotes exercise performance via controlling the excess reactive oxygen species production and enhancing mitochondrial function in skeletal muscle. Metabolism. 65(5). 747–756. 67 indexed citations
18.
Ni, Min. (2011). Analysis of relapse cases in heroin abusers. 1 indexed citations
19.
Zhang, Yi, Ren Liu, Min Ni, Parkash S. Gill, & Amy S. Lee. (2010). Cell Surface Relocalization of the Endoplasmic Reticulum Chaperone and Unfolded Protein Response Regulator GRP78/BiP. Journal of Biological Chemistry. 285(20). 15065–15075. 262 indexed citations
20.
He, Housheng Hansen, Clifford A. Meyer, Hyunjin Shin, et al.. (2010). Nucleosome dynamics define transcriptional enhancers. Nature Genetics. 42(4). 343–347. 357 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026